The Trinity Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 5.92 M
- Company Age 79 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.05 M
- Satisfied Charges ₹ 9.89 M
- Revenue Growth 1.48%
- Profit Growth -68.22%
- Ebitda 20.31%
- Net Worth 2.21%
- Total Assets -7.22%
About The Trinity Pharmaceuticals (India)
The Trinity Pharmaceuticals (India) Pvt Ltd (TTPIPL) was founded in India on 12 November 1945 and has a glorious history of 79 years and three months.Its registered office is in Thrissur, Kerala, India.
The Corporate was formerly known as The Trinity Pharmaceuticals (India) Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 5.92 M.
The company currently has active open charges totaling ₹8.05 M. The company has closed loans amounting to ₹9.89 M, as per Ministry of Corporate Affairs (MCA) records.
Anand Aravind, Ranjith Damodaran, and Ajay Jagan serve as directors at the Company.
Company Details
- Location
Thrissur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231KL1945PTC001682
- Company No.
001682
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 1945
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at The Trinity Pharmaceuticals (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjith Damodaran  | Managing Director | 11-Jul-2009 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Jagan | Director | 10-Jun-1996 | Current |
| Anand Aravind | Director | 10-Jun-1996 | Current |
Financial Performance of The Trinity Pharmaceuticals (India).
The Trinity Pharmaceuticals (India) Pvt Ltd, for the financial year ended 2023, experienced modest growth in revenue, with a 1.48% increase. The company also saw a substantial fall in profitability, with a 68.22% decrease in profit. The company's net worth moved up by a moderate rise of 2.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of The Trinity Pharmaceuticals (India)?
In 2023, The Trinity Pharmaceuticals (India) had a promoter holding of 67.52% and a public holding of 32.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.05 M
₹9.89 M
Charges Breakdown by Lending Institutions
- Others : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2019 | Others | ₹8.05 M | Open |
| 05 Aug 2008 | State Bank Of Travancore | ₹4.50 M | Satisfied |
| 07 Feb 2004 | The Dharmodayam Company | ₹0.04 M | Satisfied |
| 07 Jan 2004 | State Bank Of Travancore | ₹1.20 M | Satisfied |
| 31 Jan 2003 | State Bank Of Travancore | ₹2.60 M | Satisfied |
How Many Employees Work at The Trinity Pharmaceuticals (India)?
Unlock and access historical data on people associated with The Trinity Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of The Trinity Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped The Trinity Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
